Therapeutics, Inc
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About LENZ
LENZ Therapeutics, Inc. is a pre-commercial stage biopharmaceutical company. The Company is focused on the development and commercialization of aceclidine-based eye drop to improve near vision in patients with presbyopia. The Company’s lead product candidate LNZ100 is a preservative-free, single-use, once-daily eye drop containing aceclidine. LNZ100 was evaluated in the registration-enabling Phase III CLARITY study as a potential therapy for the treatment of presbyopia, a condition impacting over 1.8 billion people globally and 128 million people in the United States. Its other product LNZ101, is a preservative-free eye drop containing aceclidine and brimonidine.
Find out what a historical investment in Therapeutics, Inc would be worth today using our LENZ stock calculator.
$317.62M
-
0.00%
68.37K
$10.39
$9.94
$10.12
$50.40
$8.25
Ready to start your investing journey with Stake?
Open an accountLENZ FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in LENZ
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in LENZ
on Stake
Buy LENZ from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of LENZ from only US$10 with fractional shares
